Context Therapeutics Inc. (CNTX)
Pharmaceutical Preparations
Latest Price
$0.60
TTM P/E
--
Normalized P/E
0.29
Div Yield
--
Book Value
0.55
P/B Ratio
1.09
Institutional Ownership
79.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 10.68M | $27.0M | 11.62% | -- | 2026-03-31 |
| Nextech Invest, Ltd. | 7.42M | $19.0M | 8.08% | -- | 2026-03-31 |
| Deep Track Capital, LP | 7.42M | $19.0M | 8.08% | -- | 2026-03-31 |
| Soleus Capital Management, L.P. | 6.96M | $18.0M | 7.58% | -- | 2026-03-31 |
| Octagon Capital Advisors LP | 5.25M | $13.0M | 5.71% | -- | 2026-03-31 |
| Blue Owl Capital Holdings LP | 5.09M | $13.0M | 5.54% | -2.34M | 2026-03-31 |
| Avidity Partners Management LP | 5.00M | $11.0M | 5.44% | -506.6K | 2026-03-31 |
| FRANKLIN RESOURCES INC | 3.80M | $9.0M | 4.14% | -200.0K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.43M | $8.0M | 3.74% | -- | 2026-03-31 |
| MARSHALL WACE, LLP | 2.95M | $7.0M | 3.21% | +355.2K | 2026-03-31 |